» Articles » PMID: 19061838

Hepatic Stem-like Phenotype and Interplay of Wnt/beta-catenin and Myc Signaling in Aggressive Childhood Liver Cancer

Abstract

Hepatoblastoma, the most common pediatric liver cancer, is tightly linked to excessive Wnt/beta-catenin signaling. Here, we used microarray analysis to identify two tumor subclasses resembling distinct phases of liver development and a discriminating 16-gene signature. beta-catenin activated different transcriptional programs in the two tumor types, with distinctive expression of hepatic stem/progenitor markers in immature tumors. This highly proliferating subclass was typified by gains of chromosomes 8q and 2p and upregulated Myc signaling. Myc-induced hepatoblastoma-like tumors in mice strikingly resembled the human immature subtype, and Myc downregulation in hepatoblastoma cells impaired tumorigenesis in vivo. Remarkably, the 16-gene signature discriminated invasive and metastatic hepatoblastomas and predicted prognosis with high accuracy.

Citing Articles

Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma.

Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J Curr Oncol. 2025; 32(1).

PMID: 39851951 PMC: 11763369. DOI: 10.3390/curroncol32010035.


"Update on pediatric primary liver tumors".

Lopez-Terrada D, Stahlschmidt J, Perez-Atayde A Virchows Arch. 2025; 486(1):23-47.

PMID: 39836187 DOI: 10.1007/s00428-024-03985-4.


Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?.

Wang W, Du Y, Datta S, Fowler J, Sang H, Albadari N Genes Dis. 2025; 12(2):101156.

PMID: 39802403 PMC: 11719324. DOI: 10.1016/j.gendis.2023.101156.


Asynchronous Transitions from Hepatoblastoma to Carcinoma in High-Risk Pediatric Tumors.

Yu X, Sarabia S, Urbicain M, Somvanshi S, Patel R, Tran T bioRxiv. 2025; .

PMID: 39763896 PMC: 11703271. DOI: 10.1101/2024.12.24.630261.


Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma.

Requena D, Medico J, Soto-Ugaldi L, Shirani M, Saltsman 3rd J, Torbenson M Nat Commun. 2024; 15(1):10887.

PMID: 39738196 PMC: 11685927. DOI: 10.1038/s41467-024-55238-2.